Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in demand for the company’s blockbuster psoriasis treatment.
Christopher Sayed, MD, discusses how hidradenitis suppurativa typically presents and looks forward, following the November approval of bimekizumab.
NanoDefense Pro is a topical skincare formula that supports healthy nails and skin. It is made with all-natural ingredients.
SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment o ...
SAN DIEGO - Dermata Therapeutics , Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW), a biotech firm specializing in skin disease treatments, ...
Johnson & Johnson (NYSE: JNJ) stock fell 1.5%, weighed by a hefty dip in sales of its blockbuster psoriasis treatment Stelara ...
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.